DrugBank

DrugBank adds ASHP data to knowledgebase, improving user experience and data reliability

Retrieved on: 
Tuesday, November 7, 2023

EDMONTON, AB, November 7, 2023 /PRNewswire/ - DrugBank has kicked off their role as a key distributor of the American Society for Health-System Pharmacists's (ASHP) data.

Key Points: 
  • EDMONTON, AB, November 7, 2023 /PRNewswire/ - DrugBank has kicked off their role as a key distributor of the American Society for Health-System Pharmacists's (ASHP) data.
  • On a mission to remove the barriers that disorganised data presents, Mike Wilson , DrugBank CEO, sees this move as a vital step toward more effective healthcare.
  • "ASHP's data not only broadens the scope of information we're providing, it creates opportunities for bigger discoveries to happen faster than ever."
  • ASHP customers can expect increased reliability of data delivery and frequency, as well as easy access to authoritative, up-to-date, evidence-based information.

PLAMECA's QUICKISEN is a Natural Solution to Constipation

Retrieved on: 
Tuesday, September 5, 2023

FORT LAUDERDALE, Fla., Sept. 5, 2023 /PRNewswire/ -- Constipation is a common concern among all Americans. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains that constipation is common among all ages and populations in the U.S. Symptoms occur in approximately 16% of the population, with the number of cases rising to 33% among those 60 years and older. Cleveland Clinic adds that constipation most often occurs due to a change in diet or routine — as well as an inadequate intake of fiber.

Key Points: 
  • The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains that constipation is common among all ages and populations in the U.S.
  • Cleveland Clinic adds that constipation most often occurs due to a change in diet or routine — as well as an inadequate intake of fiber.
  • "Sometimes, the simplest solution to constipation is to consume foods with more fibrous content," explains Óscar Fernández, managing director of the health brand PLAMECA.
  • In other words, QUICKISEN won't have the intense effect of those stronger constipation tools.

DrugBank announces partnership with ASHP in continued efforts to improve health outcomes through data accessibility

Retrieved on: 
Wednesday, October 12, 2022

EDMONTON, AB, Oct. 12, 2022 /PRNewswire/ - DrugBank today announced their partnership with the American Society of Health-System Pharmacists (ASHP).

Key Points: 
  • EDMONTON, AB, Oct. 12, 2022 /PRNewswire/ - DrugBank today announced their partnership with the American Society of Health-System Pharmacists (ASHP).
  • DrugBank will integrate ASHP's trusted products and data into its already expansive knowledgebase before making it all available through their industry leading API .
  • ASHP customers can expect increased reliability of data delivery and frequency through DrugBank's secure and user-friendly platform.
  • This partnership will enhance DrugBank's Clinical API and ASHP's mapping capabilities and improve the healthcare industry's normalization efforts.

SwyftOps Hops into the Top Five!

Retrieved on: 
Monday, September 12, 2022

Contrasting favorably with most other options, SwyftOps training is generally live and one-on-one.

Key Points: 
  • Contrasting favorably with most other options, SwyftOps training is generally live and one-on-one.
  • System architect and CTO Plamen Ratchev added, "This is an expected validation for us.
  • SwyftOps ( www.SwyftOps.com ) was founded in 2019 in Wichita, Kansas by homecare veterans with 65+ years' experience.
  • It's both the origin of and destination for assessments and care plans, for care notes, and a permanent document archive.

RARE-X Releases New Report that Uncovers Large Number of Previously Uncounted Rare Diseases

Retrieved on: 
Tuesday, June 7, 2022

Ensuring that the true magnitude of rare diseases is understood is critical, said Charlene Son Rigby, CEO of RARE-X.

Key Points: 
  • Ensuring that the true magnitude of rare diseases is understood is critical, said Charlene Son Rigby, CEO of RARE-X.
  • If patient communities, researchers, drug developers, and policymakers are to address rare diseases, its essential to understand the magnitude of the problem.
  • The study authors developed a reproducible methodology to identify the accurate number of rare diseases.
  • The analysis showed that there are as many as 10,867 rare diseases, including genetic and non-genetic diseases.

AI Week brings together the world AI community

Retrieved on: 
Thursday, April 14, 2022

The jam-packed week also includes panels on AI career paths for kids, AI for competitive advantage and the ethics of AI; a career and talent mixer connecting AI career seekers with top companies; and a full-day academic symposium bringing together the brightest minds in AI.

Key Points: 
  • The jam-packed week also includes panels on AI career paths for kids, AI for competitive advantage and the ethics of AI; a career and talent mixer connecting AI career seekers with top companies; and a full-day academic symposium bringing together the brightest minds in AI.
  • AI Week isnt just a celebration of 20 years of AI excellence its a launching point for the next 20 years of advancement.
  • AI Week has something for everyone including sessions, networking events and socials for a range of ages and familiarity with AI.
  • AI Week will be attended by the worlds AI community, with over 500 applicants for travel bursaries from more than 35 different countries.

DrugBank: A Future of Medicine Startup Boasting 12M+ Users Secures Successful Raise to Solve the World's Exponentially-Growing Biomedical Data Problem

Retrieved on: 
Monday, April 11, 2022

Commercial interest surged and, recognizing the potential of AI and machine learning in data-driven medicine, DrugBank began commercialization.

Key Points: 
  • Commercial interest surged and, recognizing the potential of AI and machine learning in data-driven medicine, DrugBank began commercialization.
  • Community:DrugBank has 12M+ global users annually and developers have built 300+ open source and GitHub projects using DrugBank.
  • "DrugBank will become a critical infrastructure for healthcare and change the way medicine is done", adds Mike Wilson, DrugBank CEO.
  • Utilizing artificial intelligence, their team of experts gather, author, verify, and structure the latest biomedical information into one knowledge platform.

Global Drug Discovery Informatics Market Analysis Report 2021-2028 by Workflow; Mode; Services; Regions - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 18, 2021

The "Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow; By Mode; By Services; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow; By Mode; By Services; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • In 2020, the sequence analysis market segment accounted for the largest share and is likely to register a significant market growth over the study period.
  • Basic drug discovery requires the involvement of different sets of databases, sequence analysis tools, such as BLAST, FASTA, and CLUSTALW.
  • Moreover, accelerated COVID-19 drug discovery programs across the globe are further favoring the market growth.

AI in Drug Discovery Requires Extensive Chemical Libraries, Finds IDTechEx

Retrieved on: 
Wednesday, August 18, 2021

IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.

Key Points: 
  • IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.
  • For more information, please visit www.IDTechEx.com/AIDisc
    How is AI Used in Drug Discovery?
  • One of the most developed AI drug discovery technologies is its application in structure-based hit screening.
  • The application of AI in drug discovery is helping to tackle big challenges of time and cost in drug development.

AI in Drug Discovery Requires Extensive Chemical Libraries, Finds IDTechEx

Retrieved on: 
Wednesday, August 18, 2021

IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.

Key Points: 
  • IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.
  • For more information, please visit www.IDTechEx.com/AIDisc
    How is AI Used in Drug Discovery?
  • One of the most developed AI drug discovery technologies is its application in structure-based hit screening.
  • The application of AI in drug discovery is helping to tackle big challenges of time and cost in drug development.